GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Short-Term Capital Lease Obligation

Serina Therapeutics (Serina Therapeutics) Short-Term Capital Lease Obligation : $0.23 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Short-Term Capital Lease Obligation?

Serina Therapeutics's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.23 Mil.

Serina Therapeutics's quarterly Short-Term Capital Lease Obligation increased from Dec. 2022 ($0.13 Mil) to Jun. 2023 ($0.19 Mil) and increased from Jun. 2023 ($0.19 Mil) to Mar. 2024 ($0.23 Mil).

Serina Therapeutics's annual Short-Term Capital Lease Obligation increased from . 20 ($0.00 Mil) to Dec. 2021 ($0.21 Mil) but then declined from Dec. 2021 ($0.21 Mil) to Dec. 2022 ($0.13 Mil).

Serina Therapeutics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Serina Therapeutics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Short-Term Capital Lease Obligation Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22
Short-Term Capital Lease Obligation
0.21 0.13

Serina Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Mar24
Short-Term Capital Lease Obligation 0.21 - 0.13 0.19 0.23

Serina Therapeutics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Serina Therapeutics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Serina Therapeutics (Serina Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
Traded in Other Exchanges
2BO:Germany
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Website
https://www.serinatherapeutics.com
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics (Serina Therapeutics) Headlines

From GuruFocus

Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse� for Advanced Parkinson's Disease

By Marketwired • 05-15-2024